Cite

HARVARD Citation

    Bronte, G. et al. (n.d.). Anti-angiogenic drugs for second-line treatment of NSCLC patients: just new pawns on the chessboard?. Expert opinion on biological therapy. pp. 1-5. [Online]. 
  
Back to record